Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
10
Frequently Asked Questions
What is Market Cap of Actuate Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Actuate Therapeutics Inc. market cap is $56.71M.
What is the 52-week high for Actuate Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Actuate Therapeutics Inc. 52 week high is $11.99 as of March 24, 2026.
What is the 52-week low for Actuate Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Actuate Therapeutics Inc. 52 week low is $2.27 as of March 24, 2026.
What is Actuate Therapeutics Inc. stock price today?
Actuate Therapeutics Inc. stock price today is $2.29.
What was Actuate Therapeutics Inc. stock price yesterday?
Actuate Therapeutics Inc. stock price yesterday was $2.44.
What is the PE ratio of Actuate Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Actuate Therapeutics Inc.'s P/E ratio is -2.02.
What is the Price-to-Book ratio of Actuate Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Actuate Therapeutics Inc. P/B ratio is 5.1859.
What is the 50-day moving average of Actuate Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Actuate Therapeutics Inc. 50-day moving average is $4.14.
How many employees does Actuate Therapeutics Inc. have?